To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC3046 | Ldd970 |
Novel Aurora Kinase A Inhibitor
More description
|
|
| DCC3045 | Ldd-1819 |
Novel dual inhibitor of GSK-3β and aurora kinase A, increasing somatic cell plasticity and inhibiting tumorigenicity
More description
|
|
| DCC3044 | Ldc8201 |
Novel potent and selective covalent inhibitor of EGFR and Her2 exon20 insertion mutations, exhibiting selectivity over wild type EGFR and within the kinome
More description
|
|
| DCC3043 | Ldc7559 |
Novel potent inhibitor of the NOX2-dependent oxidative burst in neutrophils by activating the glycolytic enzyme phosphofructokinase-1 liver type (PFKL) and dampening flux through the pentose phosphate pathway
More description
|
|
| DCC3042 | Ldc0496 |
Novel potent and selective covalent inhibitor of EGFR and Her2 exon20 insertion mutations, exhibiting selectivity over wild type EGFR and within the kinome
More description
|
|
| DCC3041 | Lcrf-0004 |
Novel potent and selective RON receptor tyrosine kinase inhibitor
More description
|
|
| DCC3040 | Lcl-peg3-n3 |
Novel clickable linker for estrogen receptor degraders
More description
|
|
| DCC3039 | Lcb03-0110 |
Novel potent angiogenesis inhibitor, inhibiting VEGFR-2 and JAK/STAT3 signalling in primary cultured human endothelial cells and cancer cells
More description
|
|
| DCC3038 | Lcat Activator A |
Novel activator of Lecithin:cholesterol acyltransferase (LCAT) including some familial mutations, by forming a hydrophobic adduct with Cys31
More description
|
|
| DCC3037 | Lc0024 |
Novel antibiofilm coating, covalently bindng to a titanium implant surface (LC0024-Ti)
More description
|
|
| DCC3036 | L-bmaa Hydrochloride |
Neurotoxic amino acid
More description
|
|
| DCC3035 | Lb30889 |
Prodrug of LB30870 as potent, orally active, selective and direct thrombin inhibitor
More description
|
|
| DCC3034 | Lb30870 |
Potent, orally active, selective and direct thrombin inhibitor
More description
|
|
| DCC3033 | Laxaphycin B |
Natural inhibitor of the proliferation of sensitive and resistant human cancer cell lines and this inhibitory activity is strongly increased in the presence of laxaphycin A
More description
|
|
| DCC3032 | Laxaphycin A |
Natural antifungal and cytotoxic agent
More description
|
|
| DCC3031 | Laulimalide |
Microtubule stabilzer, potently inhibiting cellular proliferation in cancer cell lines
More description
|
|
| DCC3030 | Latrunculin A |
Disruptor of microfilament-mediated processes
More description
|
|
| DCC3029 | Latonduine B |
Natural F508del-CFTR trafficking corrector, targeting poly(ADP-ribose) polymerase (PARP)
More description
|
|
| DCC3028 | Latonduine A |
Natural F508del-CFTR corrector, inhibiting both PARP-3 and -16, regulating the activity of the unfolded protein response activator inositol-requiring enzyme (IRE-1) via modulation of the level of its ribosylation by PARP-16
More description
|
|
| DCC3027 | Lassbio-1911 |
Novel Potent and Selective Histone Deacetylase 6 (HDAC6) Inhibitor
More description
|
|
| DCC3026 | Lassbio-1829 Hydrochloride |
Novel orally active IKK2 inhibitor
More description
|
|
| DCC3025 | Lassbio-1524 |
Novel IKK-β inhibitor, reducing the secretion of TNF-α, IL-1β, IL-6, IL-12, IFN-γ and increased secretion of IL-10, protecting gastrointestinal homeostasis
More description
|
|
| DCC3024 | Lassbio-1366 |
Novel Adenosine A2a Receptor Agonist, Attenuating the Progression of Monocrotaline-induced Pulmonary Hypertension
More description
|
|
| DCC3023 | Lassbio-1359 |
Novel adenosine receptor agonist, inducing relaxation of corpus cavernosum; Novel selective phosphodiesterase-4 (PDE4) inhibitor associated with anti-TNF-α properties
More description
|
|
| DCC3022 | Lassbio-1135 |
Novel dual TRPV1 antagonist and TNF-alpha production inhibitor
More description
|
|
| DCC3021 | Laspartomycin C |
Lipopeptide antibiotic with activity against a range of Gram-positive bacteria including drug-resistant pathogens
More description
|
|
| DCC3020 | Lasiojasmonate A |
Natural fungal phytotoxin, activating the plant jasmonic acid pathway
More description
|
|
| DCC3019 | Las191859 |
Novel, potent and selective CRTh2 antagonist
More description
|
|
| DCC3018 | Largazole |
Potent inhibitor of histone deacetylase
More description
|
|
| DCC3017 | laquinimod Sodium |
Novel Modulator of autoimmune demyelination
More description
|
|